Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2000
04/26/2000EP0848819B1 Analytical element and method for the determination of a specific binding ligand using a vanadium bromoperoxidase as a signal-generating enzyme
04/26/2000EP0771209A4 Novel peptides
04/26/2000CN1251653A Substances to correct abasement gene product function
04/26/2000CN1251617A Gene sequencer and method
04/26/2000CN1251616A Large scale genotyping of diseases and diagnostic test for spinocerebellar ataxia type 6
04/26/2000CN1251615A Assay for measurement of DNA synthesis rates
04/26/2000CN1251611A USPA1 and USPA2 antigens of moraxelia catarrhalis
04/26/2000CN1251609A Method and product for analyzing polymers
04/26/2000CN1251593A Selection of proteins using RNA-protein fusions
04/26/2000CN1251528A Targeted system for removing tumor cells from cell populations
04/26/2000CN1251389A Ligand for regulating exogenic expression through molting hormone receptor complex
04/25/2000US6055325 Color display of chromosomes or portions of chromosomes
04/25/2000US6054634 Determining whether quantitative trait is heritable oligogenic trait in family of trees of genus eucalyptus by genomic mapping using random amplified polymorphic dna markers and correlating traits with classes of progeny
04/25/2000US6054575 Recombinant or synthetic nucleic acid of a specific nucleotide sequence or its complement; for transcription of another nucleic acid
04/25/2000US6054568 Polymer of nucleobases capable of watson/crick basepairing connected together by linkers and having terminating groups; for nucleic acid analogs which may be used in annealing, ligation, sequencing, cleavage and primer extension reactions
04/25/2000US6054565 Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2
04/25/2000US6054564 Cell line ak76 designated as atcc 55032; for automatic diagnosis of single base pair mutations
04/25/2000US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ)
04/25/2000US6054558 Amino acid sequence of isolated polypeptide from gene upregulated in endothelial cells in response to shear stress; for treatment and diagnosis of atherosclerosis, hypertension, ischemia/reperfusion, restenosis, and arterial inflammation
04/25/2000US6054438 Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
04/25/2000US6054327 Process for aligning macromolecules on a surface by passage through a meniscus
04/25/2000US6054322 Use of sialic acid determination for determining alcohol consumption
04/25/2000US6054321 Forming three-dimensional structure of a fluorescent protein, constructing model of other fluorescent protein using first as template, making mutants by replacing amino acid(s) within 5 angstroms of any atom of chromophore
04/25/2000US6054320 Includes a regent which binds to effector of arachidonic acid release in biopsy sample cells and another reagent for detectably labelling binding agent; for early, accurate diagnosis
04/25/2000US6054314 Method for collecting cells from internal organs
04/25/2000US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy
04/25/2000US6054305 Pyruvate orthophosphate dikinase gene, recombinant DNA, and process for producing pyruvate orthophosphate dikinase
04/25/2000US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups
04/25/2000US6054301 Methods of amplification using a thermostable DNA polymerase from the hyperthermophilic archaeon strain KOD1 and reagent kit therefor
04/25/2000US6054300 Recovering unknown nucleotide sequences that are adjacent to known sequences; providing circular template containing unknown sequence, annealling primer, extending primer using polymerase, producing single stranded nucleic acid product
04/25/2000US6054292 T-cell receptor protein
04/25/2000US6054286 Detecting modulators of immune response; incubation of protein kinase c with modulator and ascertaining presence of modulating activity
04/25/2000US6054285 Detecting modulators of binding activity; incubating modulator with binding domain and detecting adjustment in fluorescence
04/25/2000US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use
04/25/2000US6054283 Antibodies against human herpesvirus-6(HHV-6) and method of use
04/25/2000US6054279 Detection of nucleic acids by fluorescence quenching
04/25/2000US6054278 Classification of a bacterial isolate based on ribonucleic acid sequences and computer analysis; comparison of ribonucleic acid sequences of bacterial isolate and those stored in a computer database
04/25/2000US6054276 DNA restriction site mapping
04/25/2000US6054275 Detection methods for cryptosporidium
04/25/2000US6054274 Method of amplifying the signal of target nucleic acid sequence analyte
04/25/2000US6054272 Dyes designed for high sensitivity detection of double-stranded DNA
04/25/2000US6054270 Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus
04/25/2000US6054269 Polynucleotides and their use for detecting enterococci and streptococci bacterial strains
04/25/2000US6054268 Method and system for genotyping
04/25/2000US6054267 Isolating deoxyribonucleic acid sequences containing at least a partial coding region for an enzyme in a sample; preferential detection and recovery of target nucleic acid by probes, transforming cells and producing expression library
04/25/2000US6054266 Screening for nucleotide sequences; labeling nucleic acid, mixing in solution with probe and coupling means to form complexes, separating complexes, releasing labeled nucleic, size separating labeled nucleic acid by electrophoresis
04/25/2000US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection
04/25/2000US6054035 DNA sample preparation and electrophoresis analysis apparatus
04/25/2000CA2169283C Method of nucleic acid sequence selection
04/25/2000CA2042808C Method of extracting particular nucleic acid fragment
04/22/2000CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae
04/20/2000WO2000022439A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
04/20/2000WO2000022438A1 Assay for disease related conformation of a protein
04/20/2000WO2000022437A1 Prognostic method for anti-resorptive treatment
04/20/2000WO2000022435A1 Microarray system and process for performing biochemical reactions
04/20/2000WO2000022430A2 Neisseria genomic sequences and methods of their use
04/20/2000WO2000022425A1 Multi-array microsystem for chemical or biological analysis
04/20/2000WO2000022173A1 Quantitative analysis of hybridization patterns and intensities in oligonucleotide arrays
04/20/2000WO2000022172A1 Nucleic acid arrays
04/20/2000WO2000022171A2 Systems and methods for sequencing by hybridization
04/20/2000WO2000022170A1 Metabolic selection methods
04/20/2000WO2000022169A1 DETECTION USING Snz AND Sno GENES AND PROTEINS
04/20/2000WO2000022168A1 Carcinogen assay
04/20/2000WO2000022167A1 Method for determining transcription factor activity and its technical uses
04/20/2000WO2000022166A2 Genes for assessing cardiovascular status and compositions for use thereof
04/20/2000WO2000022165A1 Improved hybridisation assay in which excess probe is destroyed
04/20/2000WO2000022164A1 Fluorescent probes for chromosomal painting
04/20/2000WO2000022163A2 Method and kit for directly detecting nucleotide sequences, amino acid sequences or antigens
04/20/2000WO2000022162A1 Method for determining alkaline phosphatase and eliminating haemoglobin disturbances
04/20/2000WO2000022161A1 Method for determining alkaline phosphatase
04/20/2000WO2000022160A1 Methods for assessing complement activation
04/20/2000WO2000022159A1 7-alkoxycoumarins as cyp2c9 substrates
04/20/2000WO2000022158A1 Cytochrome p450 electrochemical system
04/20/2000WO2000022143A2 Protein kinase homologs
04/20/2000WO2000022142A2 Cell signaling polypeptides and nucleic acids
04/20/2000WO2000022141A2 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment
04/20/2000WO2000022130A2 Metastatic breast and colon cancer regulated genes
04/20/2000WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors
04/20/2000WO2000022128A1 Protein conjugates containing multimers of green fluorescent protein
04/20/2000WO2000022125A2 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same
04/20/2000WO2000022122A2 Genes, proteins and biallelic markers related to central nervous system disease
04/20/2000WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor
04/20/2000WO2000022115A2 Assays for identifying functional alterations in the p53 tumor suppressor
04/20/2000WO2000022112A1 Stabilized bioactive peptides and methods of identification, synthesis and use
04/20/2000WO2000022109A1 Molecular markers for determining a patient's risk of developing agranulocytosis
04/20/2000WO2000022093A2 Novel interferon stimulated and repressed genes
04/20/2000WO2000021995A1 Treatment of inflammatory disease
04/20/2000WO2000021988A2 Human ankyrin family protein
04/20/2000WO2000021987A2 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
04/20/2000WO2000021986A2 Matrix-remodeling genes
04/20/2000WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods
04/20/2000WO2000021975A1 Multiple fusion probes
04/20/2000WO2000021974A1 Nucleotide compounds including a rigid linker
04/20/2000WO2000021967A1 Functionalized silicon compounds, their synthesis and use
04/20/2000WO2000021557A1 Delta 6 fatty acid desaturase
04/20/2000WO2000021544A1 Ups (undecaprenyl diphosphate synthase)
04/20/2000WO2000021542A1 Methods for stimulating bone formation
04/20/2000WO2000021523A1 Methods for regulating bone formation
04/20/2000WO2000008465A3 Method for determining the state of materials containing keratin and suitable devices and means therefor
04/20/2000WO2000005586A3 Rna helicases modulating translation termination